VCOB yields 1.08% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, VCOB + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VCOB + PFE for your $10,000?
VCOB is an actively managed ETF seeking current income and capital appreciation. It invests in investment grade debt such as corporate, government, and mortgage-related bonds, including both US and foreign, including emerging market issuers. The portfolio may also include derivatives like options, futures, and swaps for hedging, tactical asset allocation, or enhancing returns. The fund typically maintains a dollar-weighted average duration between 3 and 10 years, based on interest rate changes. The investment process combines macroeconomic, top-down, insights with detailed bottom-up analysis, considering factors like sector allocation, security selection, and yield curve positioning. Proprietary research, quantitative analytics, and scenario-based risk testing guide investment decisions, including ESG criteria as one of multiple factors. High portfolio turnover is expected, as the management actively buys and sells holdings to capture gains, limit losses, or pursue new opportunities.
Full VCOB Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.